UID:
almafu_9959213351302883
Umfang:
1 online resource (108 p.)
Ausgabe:
1st ed.
ISBN:
9786613135162
,
9780309212830
,
0309212839
,
9781283135160
,
1283135167
,
9780309212816
,
0309212812
Anmerkung:
Description based upon print version of record.
,
""Front Matter""; ""Preface""; ""Contents""; ""A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration""; ""Summary""; ""1 Introduction""; ""2 A Risk-Characterization Framework""; ""3 Case Study of a Mitigation-Selection Decision""; ""4 Case Study of a Targeting Decision""; ""5 Case Study of a Strategic-Investment Decision""; ""6 Case Study of a Targeting Decision That Spans Food and Drug Administration Centers""; ""7 Conclusions and Future Directions""
,
""Appendix A: Letter Report on the Development of a Model for Ranking FDA Product Categories on the Basis of Health Risks""""Appendix B: Statement of Task for the Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II""; ""Appendix C: Scenarios Provided by the U.S. Food and Drug Administration to the Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II""; ""Appendix D: Biographic Information on the Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II""
,
""Appendix E: Factors Hypothesized as Important in Understanding Risk""
,
English
Weitere Ausg.:
ISBN 9780309212809
Weitere Ausg.:
ISBN 0309212804
Sprache:
Englisch
Bookmarklink
